Valuation: Electromed, Inc.

Market Cap 352M 305M 286M 261M 491M 33.62B 499M 3.37B 1.32B 16.83B 1.32B 1.29B 56.14B P/E 2026 *
35x
P/E 2027 * 28.7x
Enterprise Value 352M 305M 286M 261M 491M 33.62B 499M 3.37B 1.32B 16.83B 1.32B 1.29B 56.14B EV / Sales 2026 *
4.79x
EV / Sales 2027 * 4.21x
Free-Float
82.82%
Yield 2026 *
-
Yield 2027 * -
1 day+0.14%
1 week+1.19%
Current month+4.44%
1 month-7.50%
3 months+25.01%
6 months+75.35%
Current year+46.09%
1 week 41.42
Extreme 41.422
43.74
1 month 37.75
Extreme 37.75
44.56
Current year 23.01
Extreme 23.01
47.4
1 year 18.8
Extreme 18.805
47.4
3 years 8.8
Extreme 8.8
47.4
5 years 8.75
Extreme 8.75
47.4
10 years 3.38
Extreme 3.38
47.4
Manager TitleAgeSince
Chief Executive Officer 61 01/07/2023
Director of Finance/CFO 44 14/11/2022
Compliance Officer - 01/09/2023
Director TitleAgeSince
Chairman 69 01/07/2023
Director/Board Member 76 21/11/2014
Director/Board Member 57 15/08/2019
Date Insider Type Main position Quantity % Market Cap.
30/6/26 Tax

Chief Financial Officer

-674 0.0081%
1/12/25 Free

Director

3,000 0.0360%
1/12/25
Summers Value Partners LLC
OtherCompany 0 0%
Change 5-day change 1-year change 3-year change Capi.($)
+0.14%+1.19%+115.61%+329.70% 352M
-1.18%+2.74%+22.92%+9.58% 220B
-0.92%+1.96%-2.51%-20.17% 143B
0.00%+7.37%-16.81%+31.78% 142B
+0.53%+4.85%-49.57%+1.29% 74.91B
-0.53%+3.63%+19.16%+16.56% 53.35B
+1.06%-0.33%-15.82%-16.41% 50.13B
+0.71%+5.62%+24.11%+17.68% 42.16B
-0.63%+3.46%+39.31%+41.78% 40.63B
+2.09%+4.95%-2.04%+3.07% 33.33B
Average +0.39%+3.66%+13.43%+41.49% 80.03B
Weighted average by Cap. -0.07%+3.84%+1.76%+8.18%

Financials

2026 *2027 *
Net sales 73.6M 63.8M 59.8M 54.53M 103M 7.02B 104M 704M 275M 3.52B 276M 270M 11.73B 83.6M 72.46M 67.93M 61.94M 117M 7.98B 118M 800M 312M 3.99B 314M 307M 13.32B
Net income 10.53M 9.13M 8.56M 7.8M 14.68M 1.01B 14.92M 101M 39.34M 503M 39.55M 38.69M 1.68B 12.83M 11.12M 10.43M 9.51M 17.89M 1.22B 18.18M 123M 47.94M 613M 48.18M 47.14M 2.05B
Net Debt - -
Logo Electromed, Inc.
Electromed, Inc. develops, manufactures, markets and sells products that provide airway clearance therapy, including the SmartVest Airway Clearance System, to patients with compromised pulmonary function. It applies High Frequency Chest Wall Oscillation (HFCWO) technologies in pulmonary care for patients of all ages. The SmartVest Clearway System consists of an inflatable therapy garment, a programmable air pulse generator and a patented single-hose that delivers air pulses from the generator to the garment to create oscillatory pressure on the chest wall. The SmartVest Clearway is designed for comfort and convenience, so patients can readily fit therapy into their daily routines. The SmartVest System is primarily prescribed for patients with bronchiectasis, cystic fibrosis, and neuromuscular conditions such as cerebral palsy and amyotrophic lateral sclerosis. It also markets the Single Patient Use (SPU) SmartVest and SmartVest Wrap to health care providers in the acute care setting.
Employees
179
Date Price Change Volume
13/08/26 US$42.54 +0.14% 67,606
12/08/26 US$42.48 +0.21% 39,826
11/08/26 US$42.39 -0.45% 40,058
10/08/26 US$42.58 +0.92% 55,056
07/08/26 US$42.19 +0.36% 76,247
Trader
Investor
-
Global
-
Quality
-
ESG MSCI
-
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
3
Last Close Price
42.54USD
Average target price
40.33USD
Spread / Average Target
-5.19%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. ELMD Stock